The principal objective was to evaluate the efficacy in the vaccine as opposed to placebo in reducing cocaine use. Secondary objectives included confirming vaccine immunogenicity via IgG anti-cocaine antibody degrees and evaluating the safety and tolerability of vaccination by way of a 20 7 days examine and at 24 7 https://felixriynh.worldblogged.com/profile